This brand name is authorized in Canada, Estonia, Lithuania, United States
The drug VIBATIV contains one active pharmaceutical ingredient (API):
1
Telavancin
UNII 0701472ZG0 - TELAVANCIN HYDROCHLORIDE
|
|
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
VIBATIV Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J01XA03 | Telavancin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XA Glycopeptide antibacterials |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02330725 |
Country: EE | Ravimiamet | Identifier(s): 1538771, 1538782 |
Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1062999, 1063000 |
Country: US | FDA, National Drug Code | Identifier(s): 62847-001 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.